Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$5.20 USD
+0.25 (5.05%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $5.20 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, Aquestive Therapeutics (AQST) reported earnings of -$0.03 per share, beating the Zacks Consensus Estimate of $-0.11 per share. This reflects a positive earnings surprise of 72.73%. Look out for AQST's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year decrease of 300%.
Earnings History
Price & Consensus
Zacks News for AQST
Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates
AQST: What are Zacks experts saying now?
Zacks Private Portfolio Services